310 related articles for article (PubMed ID: 23137845)
41. Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.
Liu W; Tan Z; Xue J; Luo W; Song H; Lv X; Zheng T; Xi T; Xing Y
Appl Microbiol Biotechnol; 2016 Jul; 100(14):6219-6229. PubMed ID: 26846746
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic efficacy of the multi-epitope vaccine CTB-UE against Helicobacter pylori infection in a Mongolian gerbil model and its microRNA-155-associated immuno-protective mechanism.
Lv X; Yang J; Song H; Li T; Guo L; Xing Y; Xi T
Vaccine; 2014 Sep; 32(41):5343-52. PubMed ID: 25093281
[TBL] [Abstract][Full Text] [Related]
43. Peroral immunization with Helicobacter pylori adhesin protein genetically linked to cholera toxin A2B subunits.
Kim BO; Shin SS; Yoo YH; Pyo S
Clin Sci (Lond); 2001 Mar; 100(3):291-8. PubMed ID: 11222115
[TBL] [Abstract][Full Text] [Related]
44. Identification of two novel immunodominant UreB CD4(+) T cell epitopes in Helicobacter pylori infected subjects.
Yang WC; Chen L; Li HB; Li B; Hu J; Zhang JY; Yang SM; Zou QM; Guo H; Wu C
Vaccine; 2013 Feb; 31(8):1204-9. PubMed ID: 23306364
[TBL] [Abstract][Full Text] [Related]
45. [Cellular immunity induced by H.pylori vaccine with chitosan as adjuvant].
Gong YF; Xie Y; Zhou NJ; Chen J; Zhou XJ; Lu NH; Wang CW
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):595-9. PubMed ID: 17618575
[TBL] [Abstract][Full Text] [Related]
46. Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling.
Lucas B; Bumann D; Walduck A; Koesling J; Develioglu L; Meyer TF; Aebischer T
Infect Immun; 2001 Mar; 69(3):1714-21. PubMed ID: 11179348
[TBL] [Abstract][Full Text] [Related]
47. Epitope-loaded nanoemulsion delivery system with ability of extending antigen release elicits potent Th1 response for intranasal vaccine against Helicobacter pylori.
Yang Y; Chen L; Sun HW; Guo H; Song Z; You Y; Yang LY; Tong YN; Gao JN; Zeng H; Yang WC; Zou QM
J Nanobiotechnology; 2019 Jan; 17(1):6. PubMed ID: 30660182
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
[TBL] [Abstract][Full Text] [Related]
49. Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice.
Taylor JM; Ziman ME; Canfield DR; Vajdy M; Solnick JV
Microb Pathog; 2008 Jan; 44(1):20-7. PubMed ID: 17683897
[TBL] [Abstract][Full Text] [Related]
50. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.
Gómez-Duarte OG; Lucas B; Yan ZX; Panthel K; Haas R; Meyer TF
Vaccine; 1998 Mar; 16(5):460-71. PubMed ID: 9491500
[TBL] [Abstract][Full Text] [Related]
51. Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice.
Xie W; Zhao W; Zou Z; Kong L; Yang L
Helicobacter; 2021 Jun; 26(3):e12807. PubMed ID: 33847026
[TBL] [Abstract][Full Text] [Related]
52. Identification of H-2d restricted Th epitopes in Urease B subunit of Helicobacter pylori.
Shi Y; Wu C; Zhou WY; Mao XH; Guo G; Zou QM
Vaccine; 2007 Mar; 25(14):2583-90. PubMed ID: 17240487
[TBL] [Abstract][Full Text] [Related]
53. Inflammation, immunity, and vaccine development for Helicobacter pylori.
Müller A; Solnick JV
Helicobacter; 2011 Sep; 16 Suppl 1():26-32. PubMed ID: 21896082
[TBL] [Abstract][Full Text] [Related]
54. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection.
Lü L; Cao HD; Zeng HQ; Wang PL; Wang LJ; Liu SN; Xiang TX
Vaccine; 2009 Feb; 27(7):972-8. PubMed ID: 19111590
[TBL] [Abstract][Full Text] [Related]
55. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection.
Smythies LE; Novak MJ; Waites KB; Lindsey JR; Morrow CD; Smith PD
Vaccine; 2005 Jan; 23(7):901-9. PubMed ID: 15603891
[TBL] [Abstract][Full Text] [Related]
56. Progress in vaccine development against Helicobacter pylori.
Svennerholm AM; Lundgren A
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):146-56. PubMed ID: 17442014
[TBL] [Abstract][Full Text] [Related]
57. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
[TBL] [Abstract][Full Text] [Related]
58. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414.
Wang L; Liu XF; Yun S; Yuan XP; Mao XH; Wu C; Zhang WJ; Liu KY; Guo G; Lu DS; Tong WD; Wen AD; Zou QM
J Microbiol; 2010 Apr; 48(2):223-8. PubMed ID: 20437155
[TBL] [Abstract][Full Text] [Related]
59. A multi-epitope vaccine CTB-UE relieves Helicobacter pylori-induced gastric inflammatory reaction via up-regulating microRNA-155 to inhibit Th17 response in C57/BL6 mice model.
Lv X; Song H; Yang J; Li T; Xi T; Xing Y
Hum Vaccin Immunother; 2014; 10(12):3561-9. PubMed ID: 25483699
[TBL] [Abstract][Full Text] [Related]
60. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
Liu M; Zhong Y; Chen J; Liu Y; Tang C; Wang X; Zhang Y; Wang P; Logan SM; Chen W; Wei B
Vaccine; 2020 Mar; 38(14):3031-3041. PubMed ID: 32139315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
